BridgeMD
New treatment option for Fever
Official title Remote Temperature Monitoring of Patients At Risk for Developing Fever
ClinicalTrials.gov ID: NCT06752512
What this study is testing
- What it's testing
- The purpose of this program is to evaluate remote temperature monitoring in cancer patients at risk of fever and infection due to chemotherapy treatment. The main questions it aims to answer are: does remote temperature monitoring reduce the number of days spent inpatient what out-of-pocket cost can a patient expect to incur for participating in remote temperature monitoring the number of billable CPT codes that will be generated by providing remote temperature monitoring Researchers will compare compliant and non-compliant patients to assess if compliance with remote temperature monitoring is associated with a decrease in the number of days spent inpatient.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Subject is at risk of a fever post discharge.
- Subject is ≥ 18 years or older.
- Subject has an iOS or Android phone, or is able to operate an AION provided smartphone device.
- Subject is willing to install the TempShield app on his/her phone.
- Subject is willing to allow AION to send text reminders to take temperature or complete surveys.
You likely can't join if
- Unable to provide informed consent
- people with a history of Medical Adhesive-Related Skin Injury (MARSI)
- people with no available placement that avoids open wounds or traumatized skin (burns. Blisters. Etc.)
- Non-English speakers: The mobile application is only currently available in English. Future development will include other languages.
- people receiving prophylactics that could induce fever.
- people with a silicon allergy
See the full eligibility criteria
- Subject is at risk of a fever post discharge.
- Subject is ≥ 18 years or older.
- Subject has an iOS or Android phone, or is able to operate an AION provided smartphone device.
- Subject is willing to install the TempShield app on his/her phone.
- Subject is willing to allow AION to send text reminders to take temperature or complete surveys.
- Subject is willing to take an oral temperature as directed by their care plan.
- Subject is willing to configure the phone to ensure these notifications are delivered, even when phone is in a "no notification" mode.
- Subject or subject caretaker is able and willing to complete subject surveys.
- Subject is willing and able to provide written informed consent in English.
- Subject is willing and able to comply with all program procedures, requirements, assessments, visits, and complete questionnaires.
- English speakers
- Unable to provide informed consent
- people with a history of Medical Adhesive-Related Skin Injury (MARSI)
- people with no available placement that avoids open wounds or traumatized skin (burns. Blisters. Etc.)
- Non-English speakers: The mobile application is only currently available in English. Future development will include other languages.
- people receiving prophylactics that could induce fever.
- people with a silicon allergy
- Subject does not have iOS or Android phone, and is unable to operate an AION provided smartphone device.
- people who are not willing to take an oral temperature per their care plan.
The study team makes the final eligibility decision.
Where it's taking place
- Schenectady, New York, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Schenectady, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.